XML 37 R23.htm IDEA: XBRL DOCUMENT
v3.26.1

Financial Instruments and Risk Management | 12 Months Ended
--- | ---
Feb. 28, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Financial Instruments and Risk Management | Note 15 - Financial Instruments and Risk Management Foreign Currency Risk The U.S. Dollar is the functional currency for the Company and all of its subsidiaries and is also the reporting currency for the Company. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales and operating expenses. As a result of such transactions, portions of our cash, accounts receivable and accounts payable are denominated in foreign currencies. Approximately 15% of our net sales revenue was denominated in foreign currencies during fiscal 2026 and approximately 14% during both fiscal 2025 and 2024. These sales were primarily denominated in Euros, British Pounds and Canadian Dollars. We make most of our inventory purchases from manufacturers in Asia and primarily use the U.S. Dollar for such purchases. In our consolidated statements of (loss) income, foreign currency exchange rate gains and losses resulting from the remeasurement of foreign income tax receivables and payables and deferred income tax assets and liabilities are recognized in income tax expense (benefit), and all other foreign currency exchange rate gains and losses are recognized in SG&A. We recorded in income tax expense (benefit) a foreign currency exchange rate net gain of $0.4 million during fiscal 2026, a net loss of $0.7 million during fiscal 2025 and a net gain of $0.3 million during fiscal 2024. We recorded in SG&A a foreign currency exchange rate net gain of $3.2 million during fiscal 2026 and net losses of $1.5 million and $0.5 million during fiscal 2025 and 2024, respectively. We mitigate certain foreign currency exchange rate risk by using forward contracts to protect against the foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. We do not enter into any derivatives or similar instruments for trading or other speculative purposes. Certain of our forward contracts are designated as cash flow hedges (“foreign currency contracts”). Foreign currency derivatives for which we have not elected hedge accounting consist of certain forward contracts. These undesignated derivatives are used to hedge monetary net asset and liability positions. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness. For additional information on our accounting for derivatives see Note 1. Interest Rate Risk Interest on our outstanding debt as of February 28, 2026 and February 28, 2025 is based on variable floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on a portion of our outstanding principal balance under the Amended Credit Agreement, which totaled $785.5 million and $921.9 million as of February 28, 2026 and February 28, 2025, respectively. As of February 28, 2026 and February 28, 2025, $325 million and $550 million of the outstanding principal balance under the Amended Credit Agreement, respectively, was hedged with interest rate swaps to fix the interest rate we pay. Our interest rate swaps are designated as cash flow hedges, and we evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness. For additional information on our accounting for derivatives see Note 1. The following tables summarize the fair values of our derivative instruments at the end of fiscal 2026 and 2025:
(in thousands) | February 28, 2026
Derivatives designated as hedging instruments | Hedge Type |  | Final Settlement Date |  | Notional Amount |  | Prepaid Expenses and Other Current Assets |  | Other Assets |  | Accrued Expenses and Other Current Liabilities |  | Other Liabilities, Non-Current
Forward contracts - sell Euro | Cash flow |  | 11/2027 |  | € | 67,000 |  |  | $ | 149 |  |  | $ | 137 |  |  | $ | 1,239 |  |  | $ | — |
Forward contracts - sell Canadian Dollars | Cash flow |  | 10/2027 |  | $ | 29,600 |  |  | 23 |  |  | 8 |  |  | 330 |  |  | — |
Forward contracts - sell Pounds | Cash flow |  | 12/2027 |  | £ | 32,000 |  |  | — |  |  | 33 |  |  | 1,174 |  |  | 42 |
Forward contracts - sell Norwegian Kroner | Cash flow |  | 2/2027 |  | kr | 30,000 |  |  | — |  |  | — |  |  | 156 |  |  | — |
Interest rate swaps (1) | Cash flow |  | 8/2027 |  | $ | 425,000 |  |  | 381 |  |  | — |  |  | 130 |  |  | 66 |
Subtotal |  |  |  |  |  |  | 553 |  |  | 178 |  |  | 3,029 |  |  | 108 |
Derivatives not designated under hedge accounting |  |  |  |  |  |  |  |  |  |  |  |  |
Forward contracts - sell Euro | (2) |  | 3/2026 |  | € | 6,764 |  |  | 25 |  |  | — |  |  | — |  |  | — |
Forward contracts - buy Pounds | (2) |  | 3/2026 |  | £ | 787 |  |  | — |  |  | — |  |  | 13 |  |  | — |
Subtotal |  |  |  |  |  |  | 25 |  |  | — |  |  | 13 |  |  | — |
Total fair value |  |  |  |  |  |  | $ | 578 |  |  | $ | 178 |  |  | $ | 3,042 |  |  | $ | 108 |
(in thousands) | February 28, 2025
Derivatives designated as hedging instruments | Hedge Type |  | Final Settlement Date |  | Notional Amount |  | Prepaid Expenses and Other Current Assets |  | Other Assets |  | Accrued Expenses and Other Current Liabilities |  | Other Liabilities, Non-Current
Forward contracts - sell Euro | Cash flow |  | 2/2026 |  | € | 35,000 |  |  | $ | 1,266 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Forward contracts - sell Canadian Dollars | Cash flow |  | 2/2026 |  | $ | 8,000 |  |  | 38 |  |  | — |  |  | — |  |  | — |
Forward contracts - sell Pounds | Cash flow |  | 2/2026 |  | £ | 24,950 |  |  | 788 |  |  | — |  |  | 99 |  |  | — |
Forward contracts - sell Norwegian Kroner | Cash flow |  | 8/2025 |  | kr | 10,000 |  |  | 71 |  |  | — |  |  | — |  |  | — |
Interest rate swaps | Cash flow |  | 8/2026 |  | $ | 550,000 |  |  | 763 |  |  | 302 |  |  | 221 |  |  | — |
Subtotal |  |  |  |  |  |  | 2,926 |  |  | 302 |  |  | 320 |  |  | — |
Derivatives not designated under hedge accounting |  |  |  |  |  |  |  |  |  |  |  |  |
Forward contracts - sell Euro | (2) |  | 3/2025 |  | € | 680 |  |  | — |  |  | — |  |  | 2 |  |  | — |
Forward contracts - sell Pounds | (2) |  | 3/2025 |  | £ | 1,280 |  |  | — |  |  | — |  |  | 18 |  |  | — |
Subtotal |  |  |  |  |  |  | — |  |  | — |  |  | 20 |  |  | — |
Total fair value |  |  |  |  |  |  | $ | 2,926 |  |  | $ | 302 |  |  | $ | 340 |  |  | $ | — |
(1)Includes a forward-starting interest rate swap agreement effective March 1, 2026 with a notional amount of $100 million. (2)These forward contracts, for which we have not elected hedge accounting, hedge monetary net asset and liability positions for the notional amounts reported, creating an economic hedge against currency movements. The pre-tax effects of derivative instruments designated as cash flow hedges for fiscal 2026 and 2025 were as follows:
| Fiscal Years Ended Last Day of February,
| Gain (Loss) Recognized in AOCI | Gain (Loss) Reclassified from AOCI into Income
(in thousands) | 2026 |  |  |  | 2025 |  | Location |  | 2026 |  | 2025 |  |
Foreign currency contracts - cash flow hedges | $ | (11,492) |  |  |  |  | $ | 3,294 |  |  | Sales revenue, net |  | $ | (6,837) |  |  | $ | 1,441 |  |  |
Interest rate swaps - cash flow hedges | 2,289 |  |  |  |  | 2,401 |  |  | Interest expense |  | 2,948 |  |  | 4,061 |  |  |
Total | $ | (9,203) |  |  |  |  | $ | 5,695 |  |  |  |  | $ | (3,889) |  |  | $ | 5,502 |  |  |
The pre-tax effects of derivative instruments not designated under hedge accounting for fiscal 2026 and 2025 were as follows:
|  | Fiscal Years Ended Last Day of February,
|  | Gain (Loss) Recognized in Income
(in thousands) |  | Location |  | 2026 |  | 2025
Forward contracts |  | SG&A |  | $ | (645) |  |  | $ | 76 |
Total |  |  |  | $ | (645) |  |  | $ | 76 |
We expect a net loss of $2.5 million associated with foreign currency contracts and interest rate swaps currently recorded in AOCI to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle. See Notes 1, 14 and 16 for more information. Counterparty Credit Risk Financial instruments, including foreign currency contracts, forward contracts and interest rate swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. We believe that the risk of incurring credit losses is remote.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/825/tableOfContent + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration